Olive Clinical Research Center and MHS Patent Office Sign Cooperation Agreement to Strengthen Intellectual Property

[Asia Economy Reporter Lee Gwanju] Olive Clinical Research Center (ACRC) announced on the 28th that it has signed a ‘Strategic Business Agreement for Strengthening Intellectual Property Cooperation’ with MHS Patent Office.

?

Through this agreement, both parties will cooperate to secure joint intellectual property rights such as domestic and international patent applications, trademarks, and designs for clients outsourcing human application trials, with a focus on ‘protecting intellectual property rights for new research achievements.’

?

ACRC is a health and beauty clinical trial contract research organization (CRO) that verifies the functionality and efficacy of cosmetics, health functional foods, quasi-drugs, and more. It conducts clinical trials in compliance with the Ministry of Food and Drug Safety guidelines and Good Clinical Practice (GCP), and operates an independent Institutional Review Board (IRB) to protect the rights of subjects and oversee the validity review and management of research.

?

MHS is a specialized patent law firm that provides demand-oriented intellectual property services, focusing on the creation of intellectual property rights and portfolio building.

?

Kim Seongwoo, CEO of ACRC, said, "ACRC provides customized consulting services throughout the entire product development cycle of our clients, from raw material development to formulation prescription, efficacy evaluation, approval, and IP solution provision," adding, "With this agreement, having secured a rights framework for new beauty technologies, we will actively support our clients in achieving product innovation.”

This content was produced with the assistance of AI translation services.